Evidence map›Paper›PMID 40991364›Full record

ArticleThe Plant journal : for cell and molecular biology2025

Multiple effectors trigger non-host resistance in Solanum americanum against Pseudomonas syringae.

Jieun Kim, Markéta Vlková-Žlebková, Honour C McCann, Kee Hoon Sohn

Abstract read
In one paragraph

Article in The Plant journal : for cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jieun KimDepartment of Agricultural Biotechnology, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0009-0006-0299-6587
Markéta Vlková-ŽlebkováMax Planck Institute for Biology, Tübingen, 72076, Germany.ORCID 0000-0002-0272-5115
Honour C McCannMax Planck Institute for Biology, Tübingen, 72076, Germany.ORCID 0000-0003-3061-337X
Kee Hoon SohnDepartment of Agricultural Biotechnology, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0002-9021-8649

Funding

Ministry of Agriculture, Food and Rural Affairs RS-2024-00398300National Research Foundation of Korea 2023R1A2C3002366National Research Foundation of Korea RS-2025-00512558
6 · The paper itself

Abstract

Wild plant species are threatened by diverse pathogens, but disease symptoms are rarely observed in nature. This suggests that wild plants harbor valuable sources of resistance. In this study, we show that the model bacterial pathogen Pseudomonas syringae pv. tomato (Pto) DC3000 triggered defense responses in all tested accessions of a wild Solanaceae species, Solanum americanum. Pto DC3000-triggered immunity in S. americanum required a type III secretion system. We show that seven Pto DC3000 effectors (AvrPto, HopAD1, HopAM1, HopC1, HopAA1-1, HopM1, and AvrE1) triggered hypersensitive responses (HR) in S. americanum accession SP2273. Significantly, sequential deletion of the HR-triggering effectors from Pto DC3000 resulted in enhanced virulence in S. americanum. However, the well-conserved effectors, HopM1 and AvrE1, were indispensable for virulence. We conclude that the immunity triggered by multiple effectors contributes to nonhost resistance in S. americanum against P. syringae. We propose that the identification of the corresponding disease resistance genes for HopM1 and AvrE1 in S. americanum would accelerate the development of durable immunity to P. syringae pathogens in Solanaceae crops.

Indexed as

Disease ResistancePlant DiseasesPseudomonas syringaeSolanumType III Secretion SystemsVirulenceType III Secretion Systemsbacterial pathogenesiseffectorETInon‐host resistancePseudomonas syringaeSolanum americanum

Identifiers

PMID40991364
PMCPMC12459651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.